Monascin and ankaflavin have more anti-atherosclerosis effect and less side effect involving increasing creatinine phosphokinase activity than monacolin K under the same dosages

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 1, 2013, Pages 143-150

  Lee, Chun Lin ^a   Hung, Yu Ping ^a   Hsu, Ya Wen ^b   Pan, Tzu Ming ^c  

^a NATIONAL TAITUNG UNIVERSITY   (Taiwan)

^b Sunway Biotechnology Company Limited   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY LIVER; HIGH-DENSITY LIPOPROTEIN CHOLESTEROLS; HIGHLY-CORRELATED; HYPOLIPIDEMIC; HYPOLIPIDEMIC EFFECT; LOW DENSITY LIPOPROTEINS; MONASCUS; SIDE EFFECT;

BLOOD VESSELS; BODY FLUIDS; DISEASES;

CHOLESTEROL;

ANKAFLAVIN; CREATINE KINASE; FUSED HETEROCYCLIC RINGS; LIPID; MEVINOLIN; MONASCIN; RIBOFLAVIN DERIVATIVE;

ANIMAL; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD; HAMSTER; LIPID PEROXIDATION; LIVER FUNCTION TEST; MALE; MESOCRICETUS; METABOLISM; PATHOLOGY;

ANIMALS; AORTA; ATHEROSCLEROSIS; CREATINE KINASE; CRICETINAE; FLAVINS; HETEROCYCLIC COMPOUNDS, 3-RING; LIPID PEROXIDATION; LIPIDS; LIVER FUNCTION TESTS; LOVASTATIN; MALE; MESOCRICETUS;

CRICETINAE; MONASCUS;

EID: 84872117762     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf304346r     Document Type: Article

References (34)

1. Lee, C. L.; Tsai, T. Y.; Wang, J. J.; Pan, T. M. In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia Appl. Microbiol. Biotechnol. 2006a, 70, 533-540
2. Wei, W.; Li, C.; Wang, Y.; Su, H.; Zhu, J.; Kritchevsky, D. Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus -fermented rice, red yeast rice) in cholesterol fed rabbits J. Nutr. Biochem. 2003, 14, 314-318
3. Lee, C. L.; Kung, Y. H.; Wu, C. L.; Hsu, Y. W.; Pan, T. M. Monascin and ankaflavin act as novel hypolipidemic and high-density lipoprotein cholesterol-raising agents in red mold dioscorea J. Agric. Food Chem. 2010, 58, 9013-9019
4. Endo, A.; Monacolin, K. A new hypocholesterolemic agent produced by a Monascus species. J. Antibiot. (Tokyo) 1979, 32, 852-854
5. Sylvain-Moore, H.; Worden, J. P., Jr. Lovastatin-associated rhabdomyolysis Heart Lung 1991, 20, 464-466
6. Iskra, B.; Zivko, M.; Kes, P. Rhabdomyolysis as a side effect of simvastatin treatment Acta Med. Croat. 2005, 59, 325-328
7. Yang, H. T.; Lin, S. H.; Huang, S. Y.; Chou, H. J. Acute administration of red yeast rice (Monascus purpureus) depletes tissue coenzyme Q(10) levels in ICR mice Br. J. Nutr. 2005, 93, 131-135
8. Itskovitz, H. D.; Flamenbaum, W.; De Gaetano, C.; Pritchard, K. A., Jr.; Stemerman, M. B. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia Clin. Ther. 1989, 11, 862-872
9. Kasiske, B. L.; Tortorice, K. L.; Heim-Duthoy, K. L.; Goryance, J. M.; Rao, K. V. Lovastatin treatment of hypercholesterolemia in renal transplant recipients Transplantation 1990, 49, 95-100
10. Jou, P. C.; Ho, B. Y.; Hsu, Y. W.; Pan, T. M. The effect of Monascus secondary polyketide metabolites, monascin and ankaflavin, on adipogenesis and lipolysis activity in 3T3-L1 J. Agric. Food Chem. 2010, 58, 12703-12709
11. Akihisa, T.; Tokuda, H.; Yasukawa, K.; Ukiya, M.; Kiyota, A.; Sakamoto, N.; Suzuki, T.; Tanabe, N.; Nishino, H. Azaphilones, furanoisophthalides, and amino acids from the extracts of Monascus pilosus -fermented rice (red-mold rice) and their chemopreventive effects J. Agric. Food Chem. 2005, 53, 562-565
12. Akihisa, T.; Tokuda, H.; Ukiya, M.; Kiyota, A.; Yasukawa, K.; Sakamoto, N.; Kimura, Y.; Suzuki, T.; Takayasu, J.; Nishino, H. Anti-tumor-initiating effects of monascin, an azaphilonoid pigment from the extract of Monascus pilosus fermented rice (red-mold rice) Chem. Biodiversity 2005, 2, 1305-1309
13. Lee, C. L.; Hung, H. K.; Wang, J. J.; Pan, T. M. Red mold dioscorea has greater hypolipidemic and antiatherosclerotic effect than traditional red mold rice and unfermented dioscorea in hamsters J. Agric. Food Chem. 2007, 55, 7162-7169
14. Boyd, E. The Growth of the Surface Area of Human Body; University of Minnesota Press: Minneapolis, MN, 1935.
15. American Institute of Nutrition. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J. Nutr. 1977, 107, 1340-1348.
16. Friedewald, W. T.; Levy, R. I.; Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 1972, 18, 499-502
17. Wu, W. T.; Lee, C. C.; Lee, C. J.; Subeq, Y. M.; Lee, R. P.; Hsu, B. G. Rosiglitazone ameliorates endotoxin-induced organ damage in conscious rats Biol. Res. Nurs. 2011, 13, 38-43
18. Mabile, L.; Fitoussi, G.; Periquet, B.; Schmitt, A.; Salvayre, R.; Negre-Salvayre, A. α-Tocopherol and trolox block the early intracellular events (TBARS and calcium rises) elicited by oxidized low-density lipoproteins in cultured endothelial cells Free Radical Biol. Med. 1995, 19, 177-187
19. Schimke, I.; Romaniuk, P.; Schimke, E.; Papies, B. Concentration of thiobarbituric acid-reactive substances (TBARS) in the plasma of patients with atherosclerosis with different localizations and different degrees of severity Z. Med. Laboratoriumsdiagn. 1990, 31, 176-180
20. Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 1979, 95, 351-358
21. Aoi, W.; Naito, Y.; Hung, L. P.; Uchiyama, K.; Akagiri, S.; Mizushima, K.; Yoshikawa, T. Regular exercise prevents high-sucrose diet-induced fatty liver via improvement of hepatic lipid metabolism Biochem. Biophys. Res. Commun. 2011, 413, 330-335
22. Lee, C. L.; Kung, Y. H.; Wang, J. J.; Lung, T. Y.; Pan, T. M. Enhanced hypolipidemic effect and safety of red mold dioscorea cultured in deep ocean water J. Agric. Food Chem. 2011, 59, 8199-8207
23. Hodel, C. Myopathy and rhabdomyolysis with lipid-lowering drugs Toxicol. Lett. 2002, 128, 68-159
24. Aboulafia, D. M.; Johnston, R. Simvastatin-induced rhabdomyolysis in an HIV-infected patient with coronary artery disease AIDS Patient Care STDS 2000, 14, 8-13
25. Stolcpart, R. S.; Olson, K. L.; Delate, T.; Rasmussen, J.; Rehring, T. F.; Merenich, J. A. The risk for significant creatine kinase elevation with statins Am. J. Cardiovasc. Drugs 2010, 10, 92-187
26. Su, N. W.; Lin, Y. L.; Lee, M. H.; Ho, C. Y. Ankaflavin from Monascus -fermented red rice exhibits selective cytotoxic effect and induces cell death on Hep G2 cells J. Agric. Food Chem. 2005, 53, 1949-1954
27. Meurs, I.; Van Eck, M.; Van Berkel, T. J. High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis Curr. Pharm. Des. 2010, 16, 67-1445
28. Zhang, H. L.; Tao, Y.; Guo, J.; Hu, Y. M.; Su, Z. Q. Hypolipidemic effects of chitosan nanoparticles in hyperlipidemia rats induced by high fat diet Int. Immunopharmacol. 2011, 11, 457-461
29. Matsumoto, K.; Yokoyama, S.; Gato, N. Bile acid-binding activity of young persimmon (Diospyros kaki) fruit and its hypolipidemic effect in mice Phytother. Res. 2010, 24, 205-210
30. Jang, A.; Srinivasan, P.; Lee, N. Y.; Song, H. P.; Lee, J. W.; Lee, M.; Jo, C. Comparison of hypolipidemic activity of synthetic gallic acid-linoleic acid ester with mixture of gallic acid and linoleic acid, gallic acid, and linoleic acid on high-fat diet induced obesity in C57BL/6 Cr Slc mice Chem.-Biol. Interact. 2008, 174, 109-117
31. Hemalatha, S.; Wahi, A. K.; Singh, P. N.; Chansouria, J. P. Hypolipidemic activity of aqueous extract of Withania coagulan s Dunal in albino rats Phytother. Res. 2006, 20, 614-617
32. Lee, B. H.; Hsu, W. H.; Chang, Y. Y.; Kuo, H. F.; Hsu, Y. W.; Pan, T. M. Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo Free Radical Biol. Med. 2012, 53, 2008-2016
33. Tenenbaum, A.; Fisman, E. Z. Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention? Cardiovasc. Diabetol. 2012, 11, 140-148
34. Caso, G.; Kelly, P.; McNurlan, M. A.; Lawson, W. E. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins Am. J. Cardiol. 2007, 99, 1409-1412